Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Microbiology|January 9, 2015
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producersHosam M Zowawi, Anna L Sartor, Hanna E Sidjabat, et al.
BMJ Global Health|August 24, 2025
Operationalising health in the humanitarian-development-peace nexus (HDPN) in Africa: a new framework for building resilience in countries with fragile, conflict and violence-affected settingsAmbrose Talisuna, Sohel Saikat, Redda Seifeldin, et al.
The Lancet. Infectious Diseases|July 30, 2013
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive studyAbdullah Assiri, Jaffar A Al-Tawfiq, Abdullah A Al-Rabeeah, et al.
Environmental Advances|December 5, 2022
Establishing a marine monitoring programme to assess antibiotic resistance: A case study from the Gulf Cooperation Council (GCC) regionEdel Light, Craig Baker-Austin, Roderick M Card, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producersHosam M Zowawi, Anna L Sartor, Hanan H Balkhy, et al.
The Lancet. Microbe|August 15, 2024
WHO global research priorities for antimicrobial resistance in human healthSilvia Bertagnolio, Zlatina Dobreva, Chad M Centner, et al.
Journal of Medical Microbiology|April 18, 2018
Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the regionHosam M Zowawi, Melanie W Syrmis, Timothy J Kidd, et al.
Mbio|February 20, 2014
Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirusMatthew Cotten, Simon J Watson, Alimuddin I Zumla, et al.
The Lancet. Microbe|November 9, 2021
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trialMohammad Bosaeed, Hanan H Balkhy, Sultan Almaziad, et al.
Lancet (London, England)|September 24, 2013
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic studyMatthew Cotten, Simon J Watson, Paul Kellam, et al.
Pageof 13